Damage to OHCs, a characteristic feature of NIHL/SNHL, leads to the release and sequential distribution of prestin into perilymph, CSF, and blood, making it a potential biomarker for cochlear injury [23]. The gene discussed is SLC26A5; the disease is sensorineural hearing loss disorder.